The Medicaid rate hike will mitigate headwinds in that line of Molina Healthcare's business, which has seen higher costs since the eligibility redeterminations process all but concluded earlier this year. Medical cost trend reached 6% for Medicaid in the third quarter, twice what the company projected, Chief Financial Officer Mark Keim said.

Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Financial results are s

Baird analyst Michael Ha lowered the firm’s price target on Molina Healthcare (MOH) to $331 from $405 and keeps an Outperform rating on the